Well Told Grants

Federal grant recipients / North Carolina

Federal grants to Regennova, Inc.

Durham, North Carolina · Small businesses · UEI K9VQL9BKC1A9

Regennova, Inc. in Durham, North Carolina received $1.3 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Aging Research, with $999,900. In fiscal 2025 it was awarded $349,325.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Regennova, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20221$499,900
FY 20231$500,000
FY 20240$0
FY 20251$349,325

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Regennova, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Aging Research 93.8662$999,900
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8471$349,325

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services3$1.3 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
A therapeutic role for apolipoprotein-e in the germ theory of alzheimer's dementia - abstract: a therapeutic role for apolipoprotein-e in the germ theory of ad p. Gingivalis is the keystone bacteria of periodontal disease, the 6th most common infectious disease worldwide. Half of all americans over
ASST_NON_R41AG078111_075 on USAspending
Aging ResearchMarch 16, 2023$500,000
Therapeutic reduction of cerebral amyloid angiopathy pathologies in adrd - abstract: therapeutic reduction of cerebral amyloid angiopathy pathologies in adrd cerebrovascular amyloid angiopathy or caa is a common cerebral small vessel disease that is prevalent in the elderly, a prominent comorbidity
ASST_NON_R41NS127666_075 on USAspending
Aging ResearchSeptember 9, 2022$499,900
Arginine-polyamine pathway inhibitor for treatment of adpkd - our overarching goal is to develop an orally-available, effective, and well-tolerated drug to treat adpkd patients and where our drug lacks the liver toxicities associated with tolvaptan. Adpkd is an important human disease affecting at l
ASST_NON_R44DK141418_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJuly 17, 2025$349,325

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Regennova, Inc. get?

$1.3 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Regennova, Inc. the most?

The Department of Health and Human Services, with $1.3 million in 3 awards.

What is Regennova, Inc.'s largest federal grant?

$500,000 under Aging Research, with its first action in the period on March 16, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Regennova, Inc.?

Its largest are Aging Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.

Other grant recipients in Durham

Largest federal grant recipients in North Carolina · Federal grants in North Carolina